NEW YORK, January 2, 2018 /PRNewswire/ --
Forbes reported that according to Matt Karnes of Greenwave Advisors, the CBD market is expected
to reach the $3 billion mark by 2021. Currently, 15 states that allow CBD only - this is in
addition to the 28 states plus DC that have legalized medical cannabis. A report by Research and Markets explains that one of the
major drivers for this market is Health benefits of CBD oil. Cannabis-based CBD products have a relatively high content of THC
compared with hemp-derived CBD products. As a result, cannabis-based CBD products can be used only when they are prescribed by
doctors for medical purposes. CBD oil products have several benefits, and as a result the demand for CBD oil has increased over
the years. Chineseinvestors.com, Inc. (OTC: CIIX), CV Sciences, Inc. (OTC: CVSI), Medical Marijuana, Inc. (OTC: MJNA), Terra Tech
Corp. (OTC: TRTC), Cannabis Sativa, Inc. (OTC: CBDS)
The Research and Markets report indicates the big role Ecommerce is expected to play in the legal cannabis market. According
to the report, "the latest trend gaining momentum in the market is Growing influence of online retailing. The increasing
popularity of e-commerce businesses worldwide has provided vendors with an opportunity to enhance their profit margins and
revenues. E-commerce accounted for nearly 12% of the global retail trade in 2016. Online and e-commerce channels support both
business-to-consumer (B2C) and business-to-business (B2B) operations."
Chineseinvestors.com, Inc. (OTCQB: CIIX) just earlier today announced breaking news that today provides a
post-holiday update on CBD Biotechnology Co. Ltd.'s Yantai 1985 baijui sales. ChineseInvestors.com, Inc.'s wholly owned foreign
enterprise, CBD Biotechnology Co. Ltd. has partnered with a proven leader in the Chinese baijiu market, China GuiZhou HanTai
Wine, Inc., and based on its initial marketing campaign, anticipates revenues of 12,000,000 CNY, or
$1,800,000 USD in 2018. Baijiu is a Chinese liquor made from grains or rice. Baijiu is about 104
proof (52% alcohol).
Earlier this month, the Company rolled out a digital ad campaign on Today's Headlines, a popular and fast growing mobile app
in China with over 600 million users. Online users were directed to the Company's call center to
purchase Yantai 1985. After two weeks of advertising verification, traffic debugging, click amplification, conversion improvement
and other tests, sales stabilized in the third week of December. As of December 29th, the campaign
generated revenues of 189,655 CNY, or over $29,000 USD, in just a
week. Based on these results, we expect monthly sales to reach 758,600 CNY, or over $116,000 USD, and annual sales to reach 9,000,000 CNY, or $1,350,000 USD. In addition, the Company plans to open another account on Today's Headlines to replicate this
model.
According to Summer Yun, CEO of CBD Biotechnology Co. Ltd., "CBD Biotech is entering a new
phase in the development of its online distribution model. The marketing-to-revenue ratio for the initial sales campaign on
Today's Headlines was quite favorable; therefore, CBD Biotechnology intends to significantly increase its advertising budget in
2018 to maximize revenue through this channel."
"With healthy revenue projections from baijiu sales in China, continued growth of its
hemp-infused skincare line, the recently announced spin off of CBD Biotechnology Co. Ltd. and Chinesehempoil.com, Inc., and the
expansion of the Company's core financial education business to include cryptocurrency and blockchain technology, CIIX looks
forward to delivering significant value to our shareholders in 2018," stated Warren Wang,
ChineseInvestors.com, Inc.'s CEO.
CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on
developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on
manufacturing, marketing and selling plant-based CBD products to a range of market sectors. On November
14, 2017, the company announced it has been named on Deloitte's Technology Fast 500™, an annual ranking of the fastest
growing companies in the technology, media, telecommunications, life sciences and energy tech sectors in North America. The Deloitte Technology Fast 500 is based on percentage of revenue growth from fiscal year
2013 to 2016, with CV Sciences growing by 403% during this period. 2017 marks CV Sciences' first
year named on the Deloitte's Technology Fast 500™ list.
Medical Marijuana, Inc. (OTC: MJNA) is the first-ever publicly traded cannabis company in the
United States. On December 13, 2017, the company announced that subsidiary HempMeds®
Mexico generated the largest-ever revenue month in the history of the company in November of
2017, as well as reached major milestones in its business operations. HempMeds® Mexico is
Medical Marijuana, Inc.'s distribution branch in the country, focusing on providing non-psychoactive cannabidiol products to the
people in Mexico. In order to import its CBD hemp oil to Mexico, the Company had to develop a product completely free of THC. They achieved this by isolating the CBD
within its hemp oil, thus eliminating the trace amounts of THC in its hemp oil to make RSHO-X™.
Terra Tech Corp. (OTCQX: TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible
Garden, and MediFarm LLC. Blüm's retail and medical cannabis facilities provide the highest quality medical cannabis to patients
who are looking for alternative treatments for their chronic medical conditions as well as premium cannabis to the adult-use
market in Nevada. Blüm offers a broad selection of cannabis products including; flowers,
concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces cannabis-extracted
products for regulated medical cannabis dispensaries throughout California and medical and
adult-use dispensaries in Nevada. On November 1, 2017, the company
provided an update on the planned joint venture with NuLeaf Sparks Cultivation LLC ("NuLeaf Sparks") and NuLeaf Reno Production
LLC ("NuLeaf Reno"), in Nevada. The joint venture is expected to fast track Terra Tech's
cultivation and production facilities, allowing it to increase supply of its proprietary IVXX wholesale brand to meet the growing
demand for cannabis products throughout Nevada.
Cannabis Sativa, Inc. (OTCQB: CBDS) is engaged in the licensing of cannabis related intellectual property, marketing
and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business
activities. On December 4, 2017, the company announced that its subsidiary, PrestoDoctor, is
expanding its online medical marijuana recommendation services into New York. PrestoDoctor
currently serves patients via both their online platform and with dispensary kiosks operating in California and Nevada and will now extend their online services to patients
located in the State of New York. "New York is a heavily
populated area and has a high opiate addiction," said Robert Tankson, Co-Founder and COO of
PrestoDoctor. "Through PrestoDoctor we want to bring a safer option to the New York area for
pain treatment as well as treatment of other medical conditions."
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
service agreements with the companies which are the subject to the articles posted on the Site or other editorials for
advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news.
FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media
platform. We also do not include any personal opinions, recommendations or commentary. For this release, FinancialBuzz.com
expects to be compensated three thousand dollars for financial news dissemination and PR services
by chineseinvestors.com Inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured
on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon
engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement
with Chineseinvestors.com Inc. for one hundred thousand restricted common shares for continued financial news dissemination and
PR services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR
advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information
about any companies the information contained herein is not intended to be used as the basis for investment decisions and should
not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to
buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result
from the opinions expressed on the Site, company profiles, and quotations or in other materials or presentations that it
publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on
their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition.
FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy,
as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any
investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is
suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining
whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial
situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any
investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All
materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy
and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .
For further information:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com